No. 20-1119
Amarin Pharma, Inc., et al. v. Hikma Pharmaceuticals USA Inc., et al.
Tags: 35-usc-103 graham-factors graham-v-john-deere hindsight-bias innovation innovation-protection nonobviousness-indicia objective-indicia obviousness-standard patent patent-law
Latest Conference:
2021-06-17
(distributed 2 times)
Question Presented (from Petition)
Whether a court must consider objective indicia of nonobviousness together with the other factors bearing on an obviousness challenge before making any obviousness determination.
Question Presented (AI Summary)
Whether a court must consider objective indicia of nonobviousness together with the other factors bearing on an obviousness challenge before making any obviousness determination
Docket Entries
2021-06-21
Petition DENIED.
2021-06-01
DISTRIBUTED for Conference of 6/17/2021.
2021-06-01
Reply of petitioners Amarin Pharma, Inc., et al. filed. (Distributed)
2021-05-18
Brief of respondent Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited in opposition filed.
2021-04-07
Response to motion from petitioner Amarin Pharma, Inc., et al. filed.
2021-04-07
Motion to extend the time to file a response is granted in part and the time is extended to and including May 18, 2021.
2021-04-06
Motion to extend the time to file a response from April 29, 2021 to June 14, 2021, submitted to The Clerk.
2021-03-30
Response Requested. (Due April 29, 2021)
2021-03-24
DISTRIBUTED for Conference of 4/16/2021.
2021-03-04
Brief amicus curiae of Aimed Alliance filed.
2021-03-01
Brief amicus curiae of LiquidPower Specialty Products Inc. filed.
2021-02-24
Waiver of right of respondents Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. to respond filed.
2021-02-23
Waiver of right of respondent Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited to respond filed.
2021-02-23
Brief amicus curiae of US Inventor Inc. filed.
2021-02-11
Petition for a writ of certiorari filed. (Response due March 18, 2021)
Attorneys
Aimed Alliance
Ashley C. Parrish — King & Spalding, Amicus
Amarin Pharma, Inc., et al.
Seth P. Waxman — Wilmer Cutler Pickering Hale and Dorr LLP, Petitioner
Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.
Constance S. Huttner — Windels Marx Lane & Mittendorf, LLP, Respondent
Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited
Charles Bennett Klein — Winston & Strawn LLP, Respondent
LiquidPower Specialty Products Inc.
Zachary D. Tripp — Weil, Gotshal & Manges LLP, Amicus
US Inventor Inc.